{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:10:57Z","timestamp":1710288657807},"reference-count":18,"publisher":"Universidad Nacional de Colombia","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. salud p\u00fablica"],"abstract":"<p>Determinar la seroprevalencia de anticuerpos a virus de sarampi\u00f3n, rubeola, parotiditis, hepatitis B y los tres serotipos de poliovirus en poblaci\u00f3n infantil del Departamento del Quind\u00edo, Colombia.<\/p><p><strong>M\u00e9todos<\/strong> Se colectaron muestras de sangre de 170 ni\u00f1os en edades comprendidas entre los cinco y nueve a\u00f1os de\u00a0 nueve departamentos del Quind\u00edo. Se determin\u00f3 la presencia de anticuerpos tipo IgG para sarampi\u00f3n, rubeola y parotiditis\u00a0 mediante un ELISA indirecto comercial. La inmunidad contra la poliomielitis se determin\u00f3 por la presencia de anticuerpos neutralizantes a poliovirus seg\u00fan los m\u00e9todos recomendados por OMS.<\/p><p><strong>Resultados <\/strong>De los 170 ni\u00f1os estudiados, 169 (99,41 %), 170 (100 %), and 167 (98,2 %) fueron seropositivos a\u00a0 poliovirus 1, poliovirus 2, y poliovirus 3, respectivamente. El t\u00edtulo promedio geom\u00e9trico de anticuerpos fue 178 para poliovirus tipo 1, 120 para el tipo 2 y 56 para el tipo 3. De los 170 ni\u00f1os, el 96,47 % estuvo protegido contra parotiditis y rubeola y el 86,47 % contra sarampi\u00f3n. Se demostr\u00f3 respuesta serol\u00f3gica positiva contra el virus de la\u00a0 hepatitis B solamente en el 62,35 % de las muestras.<\/p><p><strong>Conclusiones<\/strong> El programa de inmunizaci\u00f3n en el Quind\u00edo permiti\u00f3 la seroprotecci\u00f3n contra los tres serotipos de la polio, rubeola y parotiditis. Sin embargo, la poblaci\u00f3n infantil no est\u00e1 completamente protegida contra la infecci\u00f3n con sarampi\u00f3n y virus\u00a0 de la hepatitis B.<\/p><\/jats:p>","DOI":"10.15446\/rsap.v18n1.44514","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T18:46:40Z","timestamp":1461869200000},"page":"95-103","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalencia de anticuerpos a virus del sarampi\u00f3n, rubeola, parotiditis, hepatitis B y los tres serotipos de poliovirus, en ni\u00f1os de Quind\u00edo, Colombia"],"prefix":"10.15446","volume":"18","author":[{"given":"Mar\u00eda Mercedes","family":"Gonzalez de Sch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra Mar\u00eda","family":"Giraldo Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Padilla Sanabria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Sarmiento Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria Janneth","family":"Rey-Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhon Carlos","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6146","published-online":{"date-parts":[[2016,4,28]]},"reference":[{"key":"ref1","volume-title":"Polio laboratory manual","year":"2004","unstructured":"3. WHO Department of Immunization Vaccines and Biologicals. Polio laboratory manual. 4th ed. Geneva: World Health Organization; 2004."},{"key":"ref2","first-page":"1","article-title":"General principles underlying laboratory diagnosis of viral and rickettsial infections.","volume-title":"Diagnostic procedures for viral and rickettsial infections","author":"Lennette","year":"1969","unstructured":"4. Lennette EH. General principles underlying laboratory diagnosis of viral and rickettsial infections. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures for viral and rickettsial infections. New York: American Public Health Association 1-63;1969."},{"key":"ref3","article-title":"Poliovirus vaccine -live.","volume-title":"Vaccines","author":"Sutter","year":"2012","unstructured":"5. Sutter RW, Kew OM, Cochi SL, Aylward BA. Poliovirus vaccine -live. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Philadelphia: W.B. Saunders; 2012."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2012.01864.x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2010.05.004"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-2-2"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03280480044018"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00208-3"},{"key":"ref9","first-page":"207","article-title":"Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.","volume":"43","author":"Lamy","year":"1979","unstructured":"11. Lamy ME, Cornu C, Desmyter J. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium. Dev Biol Stand. 1979; 43:207-213.","journal-title":"Dev Biol Stand","ISSN":"http:\/\/id.crossref.org\/issn\/0301-5149","issn-type":"print"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00998.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.3.207"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2001.0867"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00092-13"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1086\/651611"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202541"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2012.0140"},{"key":"ref17","first-page":"302","article-title":"Immune response to second dose of MMR vaccine in Indian children.","volume":"134","author":"Gomber","year":"2011","unstructured":"19. Gomber S, Arora SK, Das S, Ramachandran VG. Immune response to second dose of MMR vaccine in Indian children. Indian J Med Res. 2011;134:302-306.","journal-title":"Indian J Med Res","ISSN":"http:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.134"}],"container-title":["Revista de Salud P\u00fablica"],"original-title":[],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T17:32:38Z","timestamp":1710264758000},"score":1,"resource":{"primary":{"URL":"http:\/\/caoni.be\/index.php\/revsaludpublica\/article\/view\/44514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,28]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,28]]}},"URL":"https:\/\/doi.org\/10.15446\/rsap.v18n1.44514","relation":{},"ISSN":["0124-0064"],"issn-type":[{"value":"0124-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,28]]}}}